The Hemojuvelin‐Hepcidin Axis as a Target for the Treatment of Anemia or Conversely Polycythemia

Authors

Naseema Gangat (ORCID: https://orcid.org/0000-0002-9104-6172)
Ayalew Tefferi (ORCID: https://orcid.org/0000-0003-4605-3821)

Institutions

Mayo Clinic (US)

Publication Details

Journal: American Journal of Hematology
Published: 2025-10-21
DOI: https://doi.org/10.1002/ajh.70120
Primary Topic: Iron Metabolism and Disorders
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

The Hemojuvelin‐Hepcidin Axis as a Target for the Treatment of Anemia or Conversely Polycythemia

Naseema Gangat, Ayalew Tefferi

Oct 21, 2025

American Journal of Hematology

Iron Metabolism and Disorders

article

The Hemojuvelin‐Hepcidin Axis as a Target for the Treatment of Anemia or Conversely Polycythemia

Naseema Gangat, Ayalew Tefferi

October 21, 2025article en

Abstract

No abstract available for this paper.

American Journal of HematologyVol. 100(12)

Mayo Clinic (US)

Openalex Percentile: Top 62%

Iron Metabolism and Disorders

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Hemojuvelin‐Hepcidin Axis as a Target for the Treatment of Anemia or Conversely Polycythemia — Naseema Gangat, Ayalew Tefferi · American Journal of Hematology (2025) | TGRS Research Map | TGRS